Ingevity Corporation $NGVT Shares Bought by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP lifted its stake in shares of Ingevity Corporation (NYSE:NGVT) by 3.0% in the 1st quarter, Holdings Channel reports. The institutional investor owned 798,709 shares of the company’s stock after acquiring an additional 23,219 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Ingevity were worth $56,889,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the stock. Millennium Management LLC grew its position in shares of Ingevity by 1.3% in the 3rd quarter. Millennium Management LLC now owns 1,189,524 shares of the company’s stock valued at $65,650,000 after buying an additional 15,562 shares during the last quarter. Royce & Associates LP lifted its position in Ingevity by 7.7% in the fourth quarter. Royce & Associates LP now owns 1,111,158 shares of the company’s stock valued at $65,758,000 after acquiring an additional 79,059 shares during the last quarter. Brown Advisory Inc. boosted its stake in Ingevity by 15.4% in the fourth quarter. Brown Advisory Inc. now owns 1,040,944 shares of the company’s stock valued at $61,603,000 after acquiring an additional 138,859 shares in the last quarter. Simcoe Capital Management LLC boosted its stake in Ingevity by 9.4% in the fourth quarter. Simcoe Capital Management LLC now owns 1,020,945 shares of the company’s stock valued at $60,420,000 after acquiring an additional 87,490 shares in the last quarter. Finally, Victory Capital Management Inc. grew its holdings in shares of Ingevity by 7.4% during the fourth quarter. Victory Capital Management Inc. now owns 867,915 shares of the company’s stock worth $51,363,000 after purchasing an additional 60,163 shares during the last quarter. Institutional investors and hedge funds own 91.59% of the company’s stock.

Ingevity Trading Up 4.2%

NYSE NGVT opened at $73.16 on Friday. The company has a debt-to-equity ratio of 22.52, a quick ratio of 0.92 and a current ratio of 1.61. The firm has a market cap of $2.54 billion, a PE ratio of 49.77 and a beta of 1.16. Ingevity Corporation has a one year low of $39.74 and a one year high of $79.29. The firm’s fifty day moving average is $71.76 and its two-hundred day moving average is $70.97.

Ingevity (NYSE:NGVT) last announced its earnings results on Wednesday, July 29th. The company reported $1.74 earnings per share for the quarter, topping the consensus estimate of $1.33 by $0.41. Ingevity had a net margin of 4.65% and a return on equity of 284.70%. The business had revenue of $314.10 million during the quarter, compared to the consensus estimate of $312.20 million. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. Analysts expect that Ingevity Corporation will post 5.05 earnings per share for the current year.

Insiders Place Their Bets

In other Ingevity news, SVP Terrance M. Dyer sold 496 shares of the stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $68.49, for a total transaction of $33,971.04. Following the completion of the sale, the senior vice president directly owned 7,202 shares of the company’s stock, valued at approximately $493,264.98. This trade represents a 6.44% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.88% of the company’s stock.

Analysts Set New Price Targets

NGVT has been the subject of several research reports. Wall Street Zen downgraded Ingevity from a “strong-buy” rating to a “buy” rating in a report on Saturday. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Ingevity in a research report on Friday, July 17th. Two equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $80.00.

Ingevity Company Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.